RhumbLine Advisers’s Climb Bio, Inc. Common Stock CLYM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-24,782	Closed	-$30.2K	–	4294
2025 Q1	$30.2K	Sell	24,782 -7,054	-22%	-$8.6K	﹤0.01%	3671
2024 Q4	$57.3K	Buy	31,836 +4,096	+15%	+$7.37K	﹤0.01%	3622
2024 Q3	$141K	Buy	27,740 +19,507	+237%	+$99.3K	﹤0.01%	3392
2024 Q2	$58.5K	Buy	+8,233	New	+$58.5K	﹤0.01%	3646